In the Prostate Imaging Reporting and Data System (PI-RADS) 3 population, the overall detection rates for prostate cancer (PC) and clinically significant PC (csPC) range from 10.3% to 55.8% and from 3.4% to 46.5%, respectively. Decision to perform only a targeted biopsy or a systematic biopsy should be associated with a lower detection rate of both PC and csPC. PI-RADS v1 or v2 seems to have no significant impact on biopsy outcomes. A prostate-specific antigen density of ≥0.15 ng/ml/ml may represent an index to decide whether to biopsy or not.

Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer. A systematic review and meta-analysis / Maggi, M.; Panebianco, V.; Mosca, A.; Salciccia, S.; Gentilucci, A.; Di Pierro, G.; Busetto, G. M.; Barchetti, G.; Campa, R.; Sperduti, I.; Del Giudice, F.; Sciarra, A.. - In: EUROPEAN UROLOGY FOCUS. - ISSN 2405-4569. - 6:3(2020), pp. 463-478. [10.1016/j.euf.2019.06.014]

Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer. A systematic review and meta-analysis

Maggi M.
Primo
;
Panebianco V.
Secondo
;
Salciccia S.;Gentilucci A.;Di Pierro G.;Busetto G. M.;Barchetti G.;Campa R.;Sperduti I.;Del Giudice F.
Penultimo
;
Sciarra A.
Ultimo
2020

Abstract

In the Prostate Imaging Reporting and Data System (PI-RADS) 3 population, the overall detection rates for prostate cancer (PC) and clinically significant PC (csPC) range from 10.3% to 55.8% and from 3.4% to 46.5%, respectively. Decision to perform only a targeted biopsy or a systematic biopsy should be associated with a lower detection rate of both PC and csPC. PI-RADS v1 or v2 seems to have no significant impact on biopsy outcomes. A prostate-specific antigen density of ≥0.15 ng/ml/ml may represent an index to decide whether to biopsy or not.
2020
multiparametric magnetic resonance; prostate cancer; prostate imaging reporting and data system 3; targeted biopsy
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer. A systematic review and meta-analysis / Maggi, M.; Panebianco, V.; Mosca, A.; Salciccia, S.; Gentilucci, A.; Di Pierro, G.; Busetto, G. M.; Barchetti, G.; Campa, R.; Sperduti, I.; Del Giudice, F.; Sciarra, A.. - In: EUROPEAN UROLOGY FOCUS. - ISSN 2405-4569. - 6:3(2020), pp. 463-478. [10.1016/j.euf.2019.06.014]
File allegati a questo prodotto
File Dimensione Formato  
Maggi_Prostate_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 1.62 MB
Formato Adobe PDF
1.62 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1300650
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 65
  • ???jsp.display-item.citation.isi??? 63
social impact